Could obinutuzumab be the new therapy for adults with primary membranous nephropathy?

Cristián Juanet, João Venda, Federico Yandian, Fernando Caravaca-Fontán, Fernando C Fervenza

Open source

DOI: 10.1080/17512433.2026.2761222
Published: 2026-11-05
Container: Expert Review of Clinical Pharmacology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/17512433.2026.2761222,
  title = {Could obinutuzumab be the new therapy for adults with primary membranous nephropathy?},
  author = {Cristián Juanet and João Venda and Federico Yandian and Fernando Caravaca-Fontán and Fernando C Fervenza},
  year = {2026},
  journal = {Expert Review of Clinical Pharmacology},
  doi = {10.1080/17512433.2026.2761222},
  url = {https://doi.org/10.1080/17512433.2026.2761222}
}

RIS

TY  - JOUR
TI  - Could obinutuzumab be the new therapy for adults with primary membranous nephropathy?
AU  - Cristián Juanet
AU  - João Venda
AU  - Federico Yandian
AU  - Fernando Caravaca-Fontán
AU  - Fernando C Fervenza
PY  - 2026
JO  - Expert Review of Clinical Pharmacology
DO  - 10.1080/17512433.2026.2761222
UR  - https://doi.org/10.1080/17512433.2026.2761222
ER  -

APA

Juanet, C., Venda, J., Yandian, F., Caravaca-Fontán, F., & Fervenza, F. C. (2026). Could obinutuzumab be the new therapy for adults with primary membranous nephropathy?. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2026.2761222

Source records

crossref · retrieved 2026-11-08T05:06:21.399Z